- Home
- Publications
- Publication Search
- Publication Details
Title
New treatments for inflammatory rheumatic disease
Authors
Keywords
Rheumatoid arthritis, Systemic lupus erythematosus, Gout, Psoriatic arthritis, Biologics
Journal
IMMUNOLOGIC RESEARCH
Volume 60, Issue 2-3, Pages 277-288
Publisher
Springer Nature
Online
2014-11-15
DOI
10.1007/s12026-014-8565-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Efficacy and safety of the anti-IL-12/23 p40 monoclonal antibody, ustekinumab, in patients with active psoriatic arthritis despite conventional non-biological and biological anti-tumour necrosis factor therapy: 6-month and 1-year results of the phase 3, multicentre, double-blind, placebo-controlled, randomised PSUMMIT 2 trial
- (2014) Christopher Ritchlin et al. ANNALS OF THE RHEUMATIC DISEASES
- Ustekinumab, an anti-IL-12/23 p40 monoclonal antibody, inhibits radiographic progression in patients with active psoriatic arthritis: results of an integrated analysis of radiographic data from the phase 3, multicentre, randomised, double-blind, placebo-controlled PSUMMIT-1 and PSUMMIT-2 trials
- (2014) Arthur Kavanaugh et al. ANNALS OF THE RHEUMATIC DISEASES
- Treatment of psoriatic arthritis in a phase 3 randomised, placebo-controlled trial with apremilast, an oral phosphodiesterase 4 inhibitor
- (2014) Arthur Kavanaugh et al. ANNALS OF THE RHEUMATIC DISEASES
- The IL-23/IL-17 axis in psoriatic arthritis
- (2014) Erika Suzuki et al. AUTOIMMUNITY REVIEWS
- Biological therapy for rheumatoid arthritis: where are we now?
- (2014) Sarah C Horton et al. BRITISH JOURNAL OF HOSPITAL MEDICINE
- One-year Efficacy and Safety Results of Secukinumab in Patients With Rheumatoid Arthritis: Phase II, Dose-finding, Double-blind, Randomized, Placebo-controlled Study
- (2014) M. C. Genovese et al. JOURNAL OF RHEUMATOLOGY
- A novel human anti-interleukin-1β neutralizing monoclonal antibody showing in vivo efficacy
- (2014) Angeline XH Goh et al. mAbs
- Brodalumab, an Anti-IL17RA Monoclonal Antibody, in Psoriatic Arthritis
- (2014) Philip J. Mease et al. NEW ENGLAND JOURNAL OF MEDICINE
- Secukinumab in Plaque Psoriasis — Results of Two Phase 3 Trials
- (2014) Richard G. Langley et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety with Ocrelizumab in Rheumatoid Arthritis: Results from the Ocrelizumab Phase III Program
- (2014) Paul Emery et al. PLoS One
- Mesenchymal stem cells, autoimmunity and rheumatoid arthritis
- (2014) J. J. El-Jawhari et al. QJM-AN INTERNATIONAL JOURNAL OF MEDICINE
- B Cells in Rheumatoid Arthritis: From Pathogenic Players to Disease Biomarkers
- (2014) Serena Bugatti et al. Biomed Research International
- A Phase II Randomized Study of Subcutaneous Ixekizumab, an Anti-Interleukin-17 Monoclonal Antibody, in Rheumatoid Arthritis Patients Who Were Naive to Biologic Agents or Had an Inadequate Response to Tumor Necrosis Factor Inhibitors
- (2014) Mark C. Genovese et al. Arthritis & Rheumatology
- A phase 2 dose-ranging study of subcutaneous tabalumab for the treatment of patients with active rheumatoid arthritis and an inadequate response to methotrexate
- (2013) Mark C Genovese et al. ANNALS OF THE RHEUMATIC DISEASES
- Janus kinase inhibitors in autoimmune diseases
- (2013) John J O'Shea et al. ANNALS OF THE RHEUMATIC DISEASES
- Efficacy and safety of secukinumab, a fully human anti-interleukin-17A monoclonal antibody, in patients with moderate-to-severe psoriatic arthritis: a 24-week, randomised, double-blind, placebo-controlled, phase II proof-of-concept trial
- (2013) Iain B McInnes et al. ANNALS OF THE RHEUMATIC DISEASES
- New Therapies for Gout
- (2013) Daria B. Crittenden et al. Annual Review of Medicine
- Tabalumab in Rheumatoid Arthritis Patients With an Inadequate Response to Methotrexate and Naive to Biologic Therapy: A Phase II, Randomized, Placebo-Controlled Trial
- (2013) M. C. Genovese et al. ARTHRITIS AND RHEUMATISM
- Inhibition of Janus kinase/signal transducer and activator of transcription (JAK/STAT) signalling pathway in rheumatoid synovial fibroblasts using small molecule compounds
- (2013) K. Migita et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Co-stimulatory molecules as targets for treatment of lupus
- (2013) Joan T. Merrill CLINICAL IMMUNOLOGY
- Role of interleukin-10 and interleukin-10 receptor in systemic lupus erythematosus
- (2013) Hui Peng et al. CLINICAL RHEUMATOLOGY
- The effectiveness of tofacitinib, a novel Janus kinase inhibitor, in the treatment of rheumatoid arthritis: a systematic review and meta-analysis
- (2013) Paweł Kawalec et al. CLINICAL RHEUMATOLOGY
- The fibroblast as a therapeutic target in rheumatoid arthritis
- (2013) Andrew Filer CURRENT OPINION IN PHARMACOLOGY
- Psoriatic arthritis: current therapy and future directions
- (2013) DoQuyen Huynh et al. EXPERT OPINION ON PHARMACOTHERAPY
- Interleukin-17A: a unique pathway in immune-mediated diseases: psoriasis, psoriatic arthritis and rheumatoid arthritis
- (2013) Bruce W. Kirkham et al. IMMUNOLOGY
- Efficacy and Safety of Belimumab in Patients with Rheumatoid Arthritis: A Phase II, Randomized, Double-blind, Placebo-controlled, Dose-ranging Study
- (2013) W. Stohl et al. JOURNAL OF RHEUMATOLOGY
- Subcutaneously Administered Ofatumumab in Rheumatoid Arthritis: A Phase I/II Study of Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics
- (2013) R. Kurrasch et al. JOURNAL OF RHEUMATOLOGY
- Expression of B Cell Activating Factor (BAFF) and BAFF-binding Receptors in Rheumatoid Arthritis
- (2013) M. J. LEANDRO et al. JOURNAL OF RHEUMATOLOGY
- BAFF and TACI Gene Expression Are Increased in Patients with Untreated Very Early Rheumatoid Arthritis
- (2013) R. A. Moura et al. JOURNAL OF RHEUMATOLOGY
- Efficacy and safety of ustekinumab in patients with active psoriatic arthritis: 1 year results of the phase 3, multicentre, double-blind, placebo-controlled PSUMMIT 1 trial
- (2013) Iain B McInnes et al. LANCET
- The role of B lymphocyte stimulator in B cell biology: implications for the treatment of lupus
- (2013) JL Scholz et al. LUPUS
- The problem of choice: current biologic agents and future prospects in RA
- (2013) Ernest H. Choy et al. Nature Reviews Rheumatology
- Meta-analysis of IL12B polymorphisms (rs3212227, rs6887695) with psoriasis and psoriatic arthritis
- (2013) Kun-Ju Zhu et al. RHEUMATOLOGY INTERNATIONAL
- A phase Ib multiple ascending dose study evaluating safety, pharmacokinetics, and early clinical response of brodalumab, a human anti-IL-17R antibody, in methotrexate-resistant rheumatoid arthritis
- (2013) David A Martin et al. ARTHRITIS RESEARCH & THERAPY
- B-cell depletion in SLE: clinical and trial experience with rituximab and ocrelizumab and implications for study design
- (2013) Venkat Reddy et al. ARTHRITIS RESEARCH & THERAPY
- Safety, tolerability, pharmacokinetics and pharmacodynamics of an anti- oncostatin M monoclonal antibody in rheumatoid arthritis: results from phase II randomized, placebo-controlled trials
- (2013) Ernest H Choy et al. ARTHRITIS RESEARCH & THERAPY
- New developments in the management of psoriasis and psoriatic arthritis: a focus on apremilast
- (2013) Andrew Palfreeman et al. Drug Design Development and Therapy
- Gout
- (2013) E. Roddy et al. BMJ-British Medical Journal
- Cell-Signaling Therapy in Rheumatoid Arthritis
- (2013) Edward Keystone et al. Current Rheumatology Reports
- Reciprocal Activation of CD4+ T Cells and Synovial Fibroblasts by Stromal Cell-Derived Factor 1 Promotes RANKL Expression and Osteoclastogenesis in Rheumatoid Arthritis
- (2013) Hae-Rim Kim et al. Arthritis & Rheumatology
- Canakinumab for acute gouty arthritis in patients with limited treatment options: results from two randomised, multicentre, active-controlled, double-blind trials and their initial extensions
- (2012) Naomi Schlesinger et al. ANNALS OF THE RHEUMATIC DISEASES
- Safety and efficacy of ocrelizumab in combination with methotrexate in MTX-naive subjects with rheumatoid arthritis: the phase III FILM trial
- (2012) William Stohl et al. ANNALS OF THE RHEUMATIC DISEASES
- The role of biosimilars in the treatment of rheumatic diseases
- (2012) Thomas Dörner et al. ANNALS OF THE RHEUMATIC DISEASES
- Tabalumab, an anti-BAFF monoclonal antibody, in patients with active rheumatoid arthritis with an inadequate response to TNF inhibitors
- (2012) Mark C Genovese et al. ANNALS OF THE RHEUMATIC DISEASES
- Rituximab in psoriatic arthritis: an exploratory evaluation
- (2012) Esther Jimenez-Boj et al. ANNALS OF THE RHEUMATIC DISEASES
- Effect of IL-17A blockade with secukinumab in autoimmune diseases
- (2012) Dhavalkumar D Patel et al. ANNALS OF THE RHEUMATIC DISEASES
- Efficacy and safety of secukinumab in patients with rheumatoid arthritis: a phase II, dose-finding, double-blind, randomised, placebo controlled study
- (2012) Mark C Genovese et al. ANNALS OF THE RHEUMATIC DISEASES
- Joint European League Against Rheumatism and European Renal Association–European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis
- (2012) George K Bertsias et al. ANNALS OF THE RHEUMATIC DISEASES
- Safety and efficacy of ocrelizumab in patients with rheumatoid arthritis and an inadequate response to at least one tumor necrosis factor inhibitor: Results of a forty-eight-week randomized, double-blind, placebo-controlled, parallel-group phase III trial
- (2012) P. P. Tak et al. ARTHRITIS AND RHEUMATISM
- Oral apremilast in the treatment of active psoriatic arthritis: Results of a multicenter, randomized, double-blind, placebo-controlled study
- (2012) Georg Schett et al. ARTHRITIS AND RHEUMATISM
- Immunomodulation in psoriatic arthritis: Focus on cellular and molecular pathways
- (2012) Maria Sole Chimenti et al. AUTOIMMUNITY REVIEWS
- Psoriatic arthritis
- (2012) Gleison Vieira Duarte et al. BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY
- Pharmacokinetic and Pharmacodynamic Properties of Canakinumab, a Human Anti-Interleukin-1β Monoclonal Antibody
- (2012) Abhijit Chakraborty et al. CLINICAL PHARMACOKINETICS
- Novel small-molecular therapeutics for rheumatoid arthritis
- (2012) Roy Fleischmann CURRENT OPINION IN RHEUMATOLOGY
- Safety and Efficacy of Various Dosages of Ocrelizumab in Japanese Patients with Rheumatoid Arthritis with an Inadequate Response to Methotrexate Therapy: A Placebo-controlled Double-blind Parallel-group Study
- (2012) M. HARIGAI et al. JOURNAL OF RHEUMATOLOGY
- IL-23A, IL-23R, IL-17A and IL-17R polymorphisms in different psoriatic arthritis clinical manifestations in the northern Italian population
- (2012) Maria Grazia Catanoso et al. RHEUMATOLOGY INTERNATIONAL
- Rilonacept (interleukin-1 trap) for prevention of gout flares during initiation of uric acid-lowering therapy: Results from a phase III randomized, double-blind, placebo-controlled, confirmatory efficacy study
- (2012) H. Ralph Schumacher et al. ARTHRITIS CARE & RESEARCH
- Body mass index, obesity, and prevalent gout in the United States in 1988-1994 and 2007-2010
- (2012) Stephen P. Juraschek et al. ARTHRITIS CARE & RESEARCH
- 2012 Update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis
- (2012) Jasvinder A. Singh et al. ARTHRITIS CARE & RESEARCH
- Rationale of anti-CD19 immunotherapy: an option to target autoreactive plasma cells in autoimmunity
- (2012) Henrik E Mei et al. ARTHRITIS RESEARCH & THERAPY
- Is Psoriatic Arthritis a Result of Abnormalities in Acquired or Innate Immunity?
- (2012) Rik J. Lories et al. Current Rheumatology Reports
- Ofatumumab, a fully human anti-CD20 monoclonal antibody, in biological-naive, rheumatoid arthritis patients with an inadequate response to methotrexate: a randomised, double-blind, placebo-controlled clinical trial
- (2011) P. C. Taylor et al. ANNALS OF THE RHEUMATIC DISEASES
- Canakinumab reduces the risk of acute gouty arthritis flares during initiation of allopurinol treatment: results of a double-blind, randomised study
- (2011) N. Schlesinger et al. ANNALS OF THE RHEUMATIC DISEASES
- European League Against Rheumatism recommendations for the management of psoriatic arthritis with pharmacological therapies
- (2011) L Gossec et al. ANNALS OF THE RHEUMATIC DISEASES
- Atacicept in patients with rheumatoid arthritis and an inadequate response to methotrexate: Results of a phase II, randomized, placebo-controlled trial
- (2011) R. F. van Vollenhoven et al. ARTHRITIS AND RHEUMATISM
- Atacicept in patients with rheumatoid arthritis and an inadequate response to tumor necrosis factor antagonist therapy: Results of a phase II, randomized, placebo-controlled, dose-finding trial
- (2011) M. C. Genovese et al. ARTHRITIS AND RHEUMATISM
- Safety and efficacy of ocrelizumab in patients with rheumatoid arthritis and an inadequate response to methotrexate: Results of a forty-eight-week randomized, double-blind, placebo-controlled, parallel-group phase III trial
- (2011) W. Rigby et al. ARTHRITIS AND RHEUMATISM
- Brief Report: A phase IIa, randomized, double-blind, placebo-controlled trial of apilimod mesylate, an interleukin-12/interleukin-23 inhibitor, in patients with rheumatoid arthritis
- (2011) Sarah Krausz et al. ARTHRITIS AND RHEUMATISM
- Emerging role for NK cells in the pathogenesis of inflammatory arthropathies
- (2011) Paola Conigliaro et al. AUTOIMMUNITY REVIEWS
- Efficacy and safety of the human anti-IL-1beta monoclonal antibody canakinumab in rheumatoid arthritis: results of a 12-week, phase II, dose-finding study
- (2011) Rieke Alten et al. BMC MUSCULOSKELETAL DISORDERS
- Pharmacokinetics, pharmacodynamics and safety of a human anti-IL-6 monoclonal antibody (sirukumab) in healthy subjects in a first-in-human study
- (2011) Zhenhua Xu et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- THERAPEUTIC HOTLINE: Abatacept: our experience of use in two patients with refractory psoriasis and psoriatic arthritis
- (2011) MaryD Altmeyer et al. Dermatologic Therapy
- The Pathogenesis of Rheumatoid Arthritis
- (2011) Iain B. McInnes et al. NEW ENGLAND JOURNAL OF MEDICINE
- Canakinumab relieves symptoms of acute flares and improves health-related quality of life in patients with difficult-to-treat Gouty Arthritis by suppressing inflammation: results of a randomized, dose-ranging study
- (2011) Naomi Schlesinger et al. ARTHRITIS RESEARCH & THERAPY
- Inhibition of fibroblast activation protein and dipeptidylpeptidase 4 increases cartilage invasion by rheumatoid arthritis synovial fibroblasts
- (2010) Caroline Ospelt et al. ARTHRITIS AND RHEUMATISM
- The efficacy and safety of abatacept in patients with non-life-threatening manifestations of systemic lupus erythematosus: Results of a twelve-month, multicenter, exploratory, phase IIb, randomized, double-blind, placebo-controlled trial
- (2010) J. T. Merrill et al. ARTHRITIS AND RHEUMATISM
- Ofatumumab, a human anti-CD20 monoclonal antibody, for treatment of rheumatoid arthritis with an inadequate response to one or more disease-modifying antirheumatic drugs: Results of a randomized, double-blind, placebo-controlled, phase I/II study
- (2010) Mikkel Østergaard et al. ARTHRITIS AND RHEUMATISM
- LY2439821, a humanized anti-interleukin-17 monoclonal antibody, in the treatment of patients with rheumatoid arthritis: A phase I randomized, double-blind, placebo-controlled, proof-of-concept study
- (2010) M. C. Genovese et al. ARTHRITIS AND RHEUMATISM
- Canakinumab for the treatment of acute flares in difficult-to-treat gouty arthritis: Results of a multicenter, phase II, dose-ranging study
- (2010) Alexander So et al. ARTHRITIS AND RHEUMATISM
- Tocilizumab in systemic lupus erythematosus: Data on safety, preliminary efficacy, and impact on circulating plasma cells from an open-label phase I dosage-escalation study
- (2010) Gabor G. Illei et al. ARTHRITIS AND RHEUMATISM
- 2010 Rheumatoid arthritis classification criteria: An American College of Rheumatology/European League Against Rheumatism collaborative initiative
- (2010) Daniel Aletaha et al. ARTHRITIS AND RHEUMATISM
- Abatacept in the treatment of patients with psoriatic arthritis: Results of a six-month, multicenter, randomized, double-blind, placebo-controlled, phase II trial
- (2010) Philip Mease et al. ARTHRITIS AND RHEUMATISM
- Actual status of antiinterleukin-1 therapies in rheumatic diseases
- (2010) Matthias Geyer et al. CURRENT OPINION IN RHEUMATOLOGY
- Epratuzumab targeting of CD22 affects adhesion molecule expression and migration of B-cells in systemic lupus erythematosus
- (2010) Capucine Daridon et al. ARTHRITIS RESEARCH & THERAPY
- Uso do abatacepte em uma paciente com artrite psoriásica
- (2010) Carlos Ewerton Maia Rodrigues et al. Revista Brasileira De Reumatologia
- Current aspects of pathogenesis in Sjögren’s syndrome
- (2010) Michael Voulgarelis et al. Therapeutic Advances in Musculoskeletal Disease
- Apremilast: a novel PDE4 inhibitor in the treatment of autoimmune and inflammatory diseases
- (2010) Georg Schett et al. Therapeutic Advances in Musculoskeletal Disease
- Heart disease and rheumatoid arthritis: understanding the risks
- (2009) S E Gabriel ANNALS OF THE RHEUMATIC DISEASES
- Induction of CCL13 expression in synovial fibroblasts highlights a significant role of oncostatin M in rheumatoid arthritis
- (2009) Christoph Hintzen et al. ARTHRITIS AND RHEUMATISM
- Cadherin 11 promotes invasive behavior of fibroblast-like synoviocytes
- (2009) Hans P. Kiener et al. ARTHRITIS AND RHEUMATISM
- Psoriatic arthritis
- (2009) Dafna D. Gladman Dermatologic Therapy
- An exploratory dose-escalating study investigating the safety, tolerability, pharmacokinetics and pharmacodynamics of intravenous atacicept in patients with systemic lupus erythematosus
- (2009) C Pena-Rossi et al. LUPUS
- Trends in cardiovascular mortality in patients with rheumatoid arthritis over 50 years: a systematic review and meta-analysis of cohort studies
- (2009) C. Meune et al. RHEUMATOLOGY
- Abatacept as an option therapy in difficult to treat psoriatic arthritis
- (2009) Francisco José Fernandes Vieira et al. RHEUMATOLOGY INTERNATIONAL
- Epidemiological studies in incidence, prevalence, mortality, and comorbidity of the rheumatic diseases
- (2009) Sherine E Gabriel et al. ARTHRITIS RESEARCH & THERAPY
- Quantitative assessment of antibodies to ribonucleoproteins in primary Sjogren syndrome: correlation with B-cell biomarkers and disease activity
- (2008) S Candon et al. ANNALS OF THE RHEUMATIC DISEASES
- Ocrelizumab, a humanized anti-CD20 monoclonal antibody, in the treatment of patients with rheumatoid arthritis: A phase I/II randomized, blinded, placebo-controlled, dose-ranging study
- (2008) Mark C. Genovese et al. ARTHRITIS AND RHEUMATISM
- Inhibition of Interleukin-1 by Anakinra Improves Vascular and Left Ventricular Function in Patients With Rheumatoid Arthritis
- (2008) Ignatios Ikonomidis et al. CIRCULATION
- Interleukin-15 stimulates macrophages to activate CD4+T cells: a role in the pathogenesis of rheumatoid arthritis?
- (2008) René Rückert et al. IMMUNOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search